Experimental therapy against ovarian cancer by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene driven by human telomerase reverse transcriptase (hTERT) promoter
Hongmei Li
Hongmei Li
Department of Obstetrics and Gynaecology, Affiliated Hospital of Yan’an University, China.